Sneha Vishwanath

This paper demonstrates the immunogenicity and efficacy of a computationally designed DNA vaccine against H1N1 influenza in swine and mice, showing broad neutralizing antibody responses and reduced viral shedding.

This paper develops a vaccine candidate using DIOSvax-H5inter nanocages that elicits cross-clade neutralising antibodies and T cell responses against diverse H5 influenza strains.

This paper introduces Spectravax, a computational method to design broad-spectrum T-cell-inducing vaccines, and demonstrates its effectiveness against Betacoronaviruses.